| 1 |
Lehman TJ, Striegel KH, Onel KB. Thalidomide thrapy for recalcitrant systemic onset juvenile rheumatoid arthritis. J Pediatr 2002;140:125-7.
DOI
ScienceOn
|
| 2 |
Ravelli A, De Benedetti F, Viola S, Martini A. Macrophage activation syndrome in systemic juvenile rheumatoid arthritis successfully treated with cyclosporine. J Pediatr 1996;128:275-8.
DOI
ScienceOn
|
| 3 |
Grondin C, Malleson P, Petty RE. Slow acting antirheumatic drugs in chronic arthritis of childhood. Semin Arthritis Rheum 1988;18:38-47.
DOI
ScienceOn
|
| 4 |
Levy ML, Barron KS, Eichenfield A. Naproxen-induced pseudo-porphyria: a distinctive photodermatitis. J Pediatr 1990;117:660-4.
DOI
|
| 5 |
Makla AL, Lempiainem M, Ylijoki H. Ibuprofen levels in serum and synovial fluid. Scand J Rheumatol Suppl 1981;39:15-7.
|
| 6 |
Dowd JE, Cimaz R, Fink CW. Nonsteroidal anti-inflammatory drug-induced gastroduodenal injury in children. Arthritis Rheum 1995;38:1225-31.
DOI
ScienceOn
|
| 7 |
Allen RC, Petty RE, Lirenman DS, Malleson PN, Laxer RM. Renal papillary necrosis in children with chronic arthritis. Am J Dis Child 1986;140:20-2.
|
| 8 |
Ramanan AV, Whitworth P, Baildam EM. Use of methotrexate in juvenile idiopathic arthritis. Arch Dis Child 2003;88:197-200.
DOI
ScienceOn
|
| 9 |
Kugathasan S, Newman AJ, Dahms BB, Boyle JT. Liver biopsy findings in patients with juvenile rheumatoid arthritis receiving long-term effect of methotrexate therapy. J Pediatr 1996;128:149-51.
DOI
ScienceOn
|
| 10 |
Cron RQ, Sherry DD, Wallace CA. Methotrexate-induced hyper-sensitivity pneumonitis in a child with juvenile rheumatoid arthritis. J Pediatr 1998;132:901-2.
DOI
ScienceOn
|
| 11 |
Michels H. What is low-dose corticosteroid therapy in juvenile idiopathic arthritis? A worldwide, questionnaire-based survey. Z Rheumatol 2000;59 Suppl 2:II/127-30.
DOI
|
| 12 |
Falcini F, Taccetti G, Trapani S, Tafi L, Volpi M. Growth retardation in juvenile chronic arthritis patients treated with steroids. Clin Exp Rheumatol 1991;9 Suppl 6:S37-40.
|
| 13 |
Adebajo AO, Hall MA. The use of intravenous pulsed methylprednisolone in the treatment of systemic-onset juvenile chronic arthritis. Br J Rheumatol 1998;37:1240-2.
DOI
|
| 14 |
Ilowite NT. Update on biologics in juvenile idiopathic arthritis. Curr Opin Rheumatol 2008;20:613-8.
DOI
ScienceOn
|
| 15 |
Wulffraat N, van Royen A, Bierings M, Vossen J, Kuis W. Autologous haemopoietic stem cell transplantation in four patients with refractory juvenile chronic arthritis. Lancet 1999;353:550-3.
DOI
ScienceOn
|
| 16 |
Haines KA. Juvenile Idiopathic Arthritis: Therapies in the 21st century. Bull NYU Hosp Jt Dis 2007;65:205-11.
|
| 17 |
Gartlehner G, Hansen RA, Jonas BL, Thieda P, Lohr KN. Biologics for the treatment of juvenile idiopathic arthritis: a systematic review and critical analysis of the evidence. Clin Rheumatol 2008;27:67-76.
DOI
|
| 18 |
Lovell DJ, Reiff A, Ilowite NT, Wallace CA, Chon Y, Lin SL, et al. Safety and efficacy of up to eight years of continuous etanercept therapy in patients with juvenile rheumatoid arthritis. Arthritis Rheum 2008;58:496-504.
|
| 19 |
Lovell DJ, Ruperto N, Goodman S. Adalimumab is safe and effective during Long-term treatment of patients with juvenile rheumatoid arthritis. Arthritis Rheum 2007;56:s292.
|
| 20 |
Cassidy JT, Petty RE. Textbook of pediatric rheumatology. 5th ed. Philadelphia : WB Saunders Co, 2006:231-60.
|
| 21 |
Keenan GF, Giannini EH, Athreya BH. Clinically significant gastropathy associated with nonsteroidal anti-inflammatory drug use in children with juvenile rheumatoid arthritis. J Rheumatol 1995;22:1149-51.
|
| 22 |
Coto C, Varela G, Hernandez V. Use of recombinant interferon gamma in pediatric patients with advanced juvenile chronic arthritis. Biotherapy 1998;11:15-20.
DOI
ScienceOn
|
| 23 |
Lovell DJ, Ruperto N, Goodman S, Reiff A, Jung L, Jarosova K, et al; Rheumatology Collaborative Study Group; Pediatric Rheumatology International Trials Organisation. Adalimumab with or without methotrexate in juvenile rheumatoid arthritis. N Engl J Med 2008;359:810-20.
DOI
ScienceOn
|
| 24 |
Ruperto N, Lovell DJ, Quartier P, Paz E, Rubio-Perez N, Silva CA, et al. Abatacept in children with juvenile idiopathic arthritis: a randomized, double-blind, placebo-controlled withdrawal trial. Lancet 2008;372:383-91.
DOI
ScienceOn
|
| 25 |
Ruperto N, Lovell DJ, Quartier P, Paz E, Rubio-Periz N, Silva CA, et al. Long-term safety and efficacy of Abatacept in children with juvenile idiopathic arthritis. Arthitis Rheum 2010;62:1792-802.
DOI
ScienceOn
|
| 26 |
Ilowite N, Porras O, Reiff A, Rudge S, Punaro M, Martin A, et al. Anakinra in the treatment of polyarticular course juvenile rheumatoid arthritis: safety and preliminary efficacy results of a randomized multicenter study. Clin Rheumatol 2009;28:129-37.
DOI
|
| 27 |
Lovell DJ, Giannini EH, Kimura Y. Preliminary evidence for sustained bioactivity of IL-1 Trap (rilonacept), a long acting IL-1 inhibitor, in systemic juvenile idiopathic arthritis. Arthritis Rheum 2007;56:S514.
|
| 28 |
Yokota s, Kishimoto T. Tocilizumab: molecular intervention therapy in children with systemic juvenile idiopathic arthritis. Expert Rev Clin Immunol 2010;6:735-43.
DOI
ScienceOn
|
| 29 |
Kiss MH, Reiff AA, Reicin AS. Rofecoxib demonstrates efficacy and tolerability in children and adolescent with juvenile rheumatoid arthritis in a 12 week randomized study. Arthritis Rheum 2003;48 Suppl 9:S650.
|
| 30 |
Cassidy JT. Medical management of children with juvenile rheumatoid arthritis. Drugs 1999;58:831-50.
DOI
ScienceOn
|
| 31 |
Ruperto N, Lovell DJ, Cuttica R. Wilkinson N, Woo P, Espada G, et al. A randomized, placebo-controlled trial of infliximab plus methotrexate for the treatment of polyarticular course juvenile rheumatoid arthritis. Arthritis Rheum 2007;56:3096-106.
DOI
ScienceOn
|
webmaster
